TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX

Rosen Law Firm is pursuing a securities class action lawsuit against MoonLake Immunotherapeutics, alleging false and misleading statements about their Nanobody technology and its clinical benefits during the period of March 10, 2024 to September 29, 2025.

Insights
MSpI   neutral

Analyst Mike Wilson provides varied scenarios from moderate pullback to potential recession, but notes earnings resilience


MLTX   negative

The lawsuit alleges the company made false statements about its Nanobody technology's clinical superiority, suggesting potential misrepresentation of scientific claims and potential investor harm